Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04062201 |
Recruitment Status :
Active, not recruiting
First Posted : August 20, 2019
Last Update Posted : October 24, 2022
|
Sponsor:
Wits Health Consortium (Pty) Ltd
Collaborators:
Regents of the University of California
University of Cape Town
Perinatal HIV Research Unit of the University of the Witswatersrand
Information provided by (Responsible Party):
Francesca Conradie, Wits Health Consortium (Pty) Ltd
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | June 2023 |
Estimated Study Completion Date : | June 2023 |
Publications: